No definition available.
Other chromosome abnormalities, not elsewhere classified
Q17_OTHER_CHROMOSOME_ABNORMALITI_NOT_ELSEW_CLASSIFIED
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
151 |
4. Check minimum number of eventsNone |
151 |
5. Include endpointsNone |
151 |
6. Filter based on genotype QC (FinnGen only) |
151 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CHROMOSOMAL_ABNORMALITI_NOT_ELSEW_CLASSIFIED
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q9
- Name in latin
- Aliae abnormitates chromosomales non alibi classificatae
Similar endpoints
↥List of similar endpoints to
Other chromosome abnormalities, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
- Chromosomal abnormalities, not elsewhere classified
- Congenital malformations, deformations and chromosomal abnormalities
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2451 | 1010 | 1439 |
| Only index persons | 1621 | 699 | 922 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.03 | 0.04 |
| Only index persons | 0.03 | 0.03 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 8.59 | 10.07 | 7.51 |
| Only index persons | 15.21 | 17.61 | 13.39 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 151 | 90 | 61 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.03 |
| Median age at first event (years) | 20.93 | 30.10 | 7.40 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 140
- Matched controls
- 1400
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q99.8
ICD-10 Finland
Other specified chromosome abnormalities
+∞
124.1
100
*
Z31.5
ICD-10 Finland
Genetic counselling
24.5
50.8
78
68
Q99.2
ICD-10 Finland
Fragile X chromosome
+∞
29.2
27
*
F83
ICD-10 Finland
Mixed specific developmental disorders
9.9
15.1
31
39
Z01.1
ICD-10 Finland
Examination of ears and hearing
4.7
12.7
49
143
Q99.9
ICD-10 Finland
Chromosomal abnormality, unspecified
+∞
12.7
12
*
R62.0
ICD-10 Finland
Delayed milestone
7.2
12.1
30
51
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
19.1
11.5
17
10
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
7.2
10.3
25
41
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
5.6
10.0
30
65
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
5.1
8.8
28
65
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
21.7
8.6
12
6
R56.8
ICD-10 Finland
Other and unspecified convulsions
5.5
8.5
25
53
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
4.8
8.3
28
69
XA800
NOMESCO Finland
Neuropsychological investigation
4.6
8.0
28
72
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.8
7.5
33
105
R1260
NOMESCO Finland
Evaluation of communicative skills
17.8
6.8
10
6
F79.1
ICD-10 Finland
Unspecified mental retardation, significant impairment of behaviour requiring attention or treatment
+∞
6.3
6
*
N03AG01
ATC
valproic acid; systemic, rectal
5.3
6.2
18
38
F80.1
ICD-10 Finland
Expressive language disorder
7.8
6.1
13
18
H01AC01
ATC
somatropin; parenteral
6.3
6.0
15
26
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40765089) Chromosome analysis panel - Blood by G-banded
11
20
5.86
5.90
1.1
1.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
90
625
2.10
4.64
14.1
13.4
mmol/l
1.2
1.2
1.07
85
582
(3018418) pH of Serum or Plasma
47
272
2.06
3.83
3.2
3.8
ph
7.4
7.4
—
5
42
(42870588) Differential panel, method unspecified - Blood
81
584
1.84
3.33
7.4
10.5
—
—
—
0
0
(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma
6
7
8.86
3.29
3.2
2.4
umol/l
16.3
28.7
—
6
7
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
7
11
6.61
3.22
1.0
1.0
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
22
101
2.38
3.11
2.6
1.9
iu/l
13.1
18.4
0.45
16
78
(3052851) Hemolysis interference index of Serum or Plasma
12
41
3.09
2.93
2.3
3.5
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
7
13
5.59
2.90
1.7
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
5
6
8.56
2.77
1.4
1.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
45
284
1.84
2.75
3.3
6.4
inr
1.0
1.1
—
8
77
(3044889) 12 lead EKG panel
75
550
1.73
2.74
2.6
2.6
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
6
10
6.20
2.72
3.2
2.0
u/ml
612.7
978.1
—
6
10
(3021387) Prolactin [Units/volume] in Serum or Plasma
18
81
2.39
2.66
2.1
1.4
mu/l
549.9
329.5
0.95
18
74
(3009214) Lutropin [Units/volume] in Serum or Plasma
17
76
2.39
2.55
2.9
2.1
u/l
8.9
8.0
—
10
52
(3006315) Basophils [#/volume] in Blood
96
788
1.61
2.03
8.2
9.5
e9/l
0.0
0.0
0.16
85
646
(3001604) Monocytes [#/volume] in Blood
96
789
1.60
2.01
8.3
9.5
e9/l
0.6
0.6
0.28
87
648
(3013115) Eosinophils [#/volume] in Blood
98
810
1.61
2.00
8.3
10.4
e9/l
0.2
0.2
0.65
89
687
(3003458) Phosphate [Moles/volume] in Serum or Plasma
42
285
1.66
1.94
5.8
11.8
mmol/l
1.3
1.4
0.77
42
268
(42529406) Shigella sp [Presence] in Stool by Culture
0
51
0.00
1.93
0.0
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
0
50
0.00
1.92
0.0
1.1
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
93
765
1.57
1.89
8.5
9.7
%
2.9
3.1
0.41
93
731
(3018010) Neutrophils/100 leukocytes in Blood
95
786
1.57
1.87
8.1
9.5
%
50.6
49.5
0.32
95
759
(3023368) Bacteria identified in Blood by Culture
39
263
1.65
1.84
3.4
4.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
16
81
2.09
1.82
3.9
2.5
u/l
876.5
5895.2
—
6
27
(3013650) Neutrophils [#/volume] in Blood by Automated count
103
871
1.58
1.82
10.6
12.7
e9/l
3.5
3.7
0.26
91
731
(3019060) Gas panel - Arterial blood
7
23
3.14
1.82
2.4
4.3
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
93
771
1.54
1.78
8.7
9.9
%
8.2
8.2
0.05
93
743
(3020564) Creatinine [Moles/volume] in Serum or Plasma
133
1205
1.92
1.76
13.2
12.5
umol/l
54.4
58.7
1.42
133
1205
(3019198) Lymphocytes [#/volume] in Blood
97
813
1.55
1.75
8.4
9.5
e9/l
2.4
2.5
0.14
89
695
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
10
42
2.48
1.71
3.1
6.9
%
61.2
50.1
—
10
42
(3007853) Bacteria identified in Skin by Aerobe culture
27
168
1.74
1.70
1.9
1.9
—
—
—
0
0
(3000991) Gas panel - Venous blood
38
260
1.62
1.69
12.1
13.6
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
6
19
3.24
1.68
2.3
3.1
umol/l
12.1
11.3
—
6
19
(3000494) Fungus identified in Specimen by Culture
19
107
1.89
1.64
1.3
1.8
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
50
368
1.54
1.63
5.1
5.3
u/l
45.0
39.3
0.13
50
352
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
6
20
3.08
1.60
1.7
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
5
15
3.41
1.53
3.6
2.5
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
5
15
3.41
1.53
6.6
3.5
ug/l
18.2
18.5
—
5
15
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
15
259
0.53
1.52
2.3
2.3
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
7
28
2.57
1.47
4.9
6.5
ug/l
2.0
2.6
—
7
28
(3051611) Lipemic interference index of Serum or Plasma
6
22
2.80
1.45
1.8
3.9
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
94
801
1.46
1.43
8.6
9.6
%
33.8
35.8
0.87
94
777
(1175426) CD3 cells/100 lymphocytes in Blood
9
40
2.33
1.43
1.7
4.7
%
65.0
62.3
—
9
40
(40761511) CBC panel - Blood by Automated count
136
1258
1.87
1.42
13.4
10.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
9
41
2.27
1.39
1.9
4.6
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
24
153
1.68
1.39
3.2
4.5
g/l
0.2
0.2
0.63
24
146
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
17
3.00
1.37
2.6
3.4
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
40
0.00
1.35
0.0
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
14
238
0.55
1.34
2.3
2.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
12
62
2.02
1.32
1.8
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
111
1216
0.66
1.31
3.9
4.1
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
30
206
1.57
1.31
2.7
7.9
s
29.6
31.5
1.02
30
206
(3000093) Morphology [Interpretation] in Blood Narrative
5
18
2.84
1.29
1.2
1.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
39
285
1.50
1.29
4.4
10.8
mmol/l
1.0
1.1
0.14
27
212
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
6
25
2.46
1.25
1.0
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
11
56
2.04
1.25
1.6
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
11
56
2.04
1.25
1.6
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
46
351
1.45
1.23
2.7
3.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
19
2.69
1.22
2.4
1.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
14
79
1.85
1.21
24.9
20.0
mmol/l
0.3
0.9
—
8
66
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
43
325
1.45
1.20
13.9
16.4
mmol/l
24.5
24.6
0.11
43
325
(3022948) Iron [Moles/volume] in Serum or Plasma
27
185
1.56
1.19
1.8
3.4
umol/l
12.7
14.0
0.56
27
179
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
5
114
0.42
1.18
1.4
1.6
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
20
2.55
1.16
1.0
1.2
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
5
20
2.55
1.16
3.6
1.8
ng/l
110.6
139.2
—
5
20
(40760892) CBC W Ordered Manual Differential panel - Blood
35
256
1.48
1.15
3.8
5.6
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
23
153
1.59
1.15
3.9
4.3
g/l
8.4
8.6
0.08
23
147
(3002582) Erythrocytes [#/volume] in Urine
53
425
1.38
1.06
2.8
4.6
e6/l
106.6
43.2
0.31
45
333
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
9
46
2.02
1.06
24.4
26.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
86
745
1.36
1.05
9.1
12.0
e9/l
0.0
0.0
0.66
73
562
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
22
2.31
1.04
4.6
4.1
%
54.4
53.8
—
5
22
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
33
244
1.45
1.03
3.0
4.4
e6/l
2.9
1.7
0.34
22
152
(40768443) Skin Pathology biopsy report
7
35
2.05
1.01
1.0
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
37
282
1.41
0.98
2.0
2.5
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
9
51
1.81
0.96
2.9
16.9
%
1.2
1.5
—
9
51
(1761868) Lipid panel - Serum or Plasma
24
326
0.69
0.90
3.3
2.1
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
6
29
2.11
0.90
1.5
1.3
g/l
0.5
0.4
—
6
24
(4062490)
6
29
2.11
0.90
1.5
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
20
137
1.53
0.90
1.9
2.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
12
72
1.72
0.88
1.4
1.9
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
39
306
1.37
0.88
2.4
3.1
mg/l
2.7
2.6
0.17
34
272
(21494755) Public health laboratory ask at order entry panel
6
113
0.51
0.87
1.3
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
58
485
1.32
0.86
1.7
1.7
g/l
1.8
1.6
0.53
35
235
(3042936) Bacteria identified in Isolate by Culture
21
147
1.50
0.86
2.8
2.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
60
505
1.31
0.85
3.7
5.5
e6/l
28.1
29.9
0.04
46
346
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
20
139
1.51
0.84
2.1
2.1
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
55
458
1.32
0.84
3.7
4.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
24
174
1.45
0.83
2.4
2.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
48
395
1.32
0.79
3.3
4.5
e6/l
0.3
0.4
0.01
40
303
(3024891) Influenza virus A+B Ag [Presence] in Specimen
14
91
1.59
0.78
1.6
1.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
57
481
1.30
0.78
7.3
9.8
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
7
38
1.88
0.74
1.7
4.3
%
19.3
24.1
—
7
38
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
31
241
1.36
0.74
2.5
4.9
mg/l
1.9
1.2
0.41
25
186
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
9
56
1.65
0.74
1.7
6.0
mmol/l
1.2
1.2
—
9
50
(3000330) Specific gravity of Urine by Test strip
7
40
1.79
0.72
4.4
2.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
28
215
1.37
0.72
2.6
2.9
ng/l
21.7
42.5
0.42
15
96
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
7
41
1.74
0.71
1.6
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
27
1.88
0.69
1.2
1.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
31
245
1.33
0.67
3.8
4.1
e6/l
1.2
0.5
0.83
21
153
(3020891) Body temperature
5
28
1.81
0.67
5.4
6.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
5
28
1.81
0.67
1.2
3.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
7
44
1.62
0.66
1.3
1.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
58
500
1.26
0.66
3.8
4.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
23
174
1.38
0.65
3.3
4.0
ng/l
321.5
696.0
0.84
17
119
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
94
858
1.26
0.64
2.9
3.0
mmol/l
5.6
5.6
0.04
88
795
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
16
113
1.47
0.64
1.0
1.3
iu/ml
116.0
118.8
—
5
42
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
51
1.60
0.61
1.5
1.6
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
20
0.00
0.61
0.0
4.4
—
—
—
0
0
(3018738) Hemoglobin F/Hemoglobin.total in Blood
0
21
0.00
0.60
0.0
4.1
—
0.3
—
0
7
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
21
0.00
0.60
0.0
1.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
22
0.00
0.60
0.0
1.0
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
22
0.00
0.60
0.0
1.8
—
0.1
—
0
5
(3012095) Magnesium [Moles/volume] in Serum or Plasma
26
204
1.33
0.59
5.2
12.8
mmol/l
0.8
0.8
0.26
26
197
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
23
0.00
0.59
0.0
1.0
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
5
90
0.54
0.57
1.8
2.4
e9/l
5.7
4.2
—
5
85
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
9
59
1.56
0.56
1.6
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
79
864
0.82
0.55
4.1
3.4
mmol/l
1.4
1.5
1.07
74
816
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
97
0.60
0.54
1.3
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
63
559
1.22
0.53
3.3
3.5
estimate
0.0
0.0
—
7
95
(3021601) Nitrite [Presence] in Urine by Test strip
62
551
1.21
0.51
4.6
5.4
estimate
0.0
0.0
—
8
99
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
80
870
0.83
0.51
4.1
3.5
mmol/l
2.8
2.8
0.13
74
822
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
55
484
1.22
0.50
1.5
1.7
u/ml
4.8
1.9
0.29
15
78
(3009261) Glucose [Presence] in Urine by Test strip
62
553
1.21
0.49
3.4
3.7
estimate
0.0
0.0
—
8
97
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
23
285
0.77
0.49
1.9
1.8
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
7
46
1.55
0.49
1.7
4.6
%
20.0
17.1
—
7
46
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
15
111
1.39
0.49
1.0
1.4
pmol/l
500.2
525.9
—
9
100
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
81
0.60
0.47
1.2
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
83
0.59
0.47
1.8
1.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
11
77
1.46
0.47
2.1
3.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
17
130
1.35
0.46
2.3
2.3
g/l
1.1
1.1
0.03
17
124
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
7
50
1.42
0.45
48.3
28.1
%
0.9
1.1
—
7
50
(3022313) Gas panel - Capillary blood
32
269
1.24
0.44
14.7
12.0
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
7
51
1.39
0.44
48.3
27.6
%
0.5
0.7
—
7
51
(3012516) Albumin [Mass/volume] in Urine
20
158
1.31
0.44
3.3
3.4
mg/l
276.9
114.3
0.48
15
108
(4035726)
6
91
0.65
0.44
1.7
1.7
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
5
31
1.63
0.43
2.6
5.2
%
90.6
94.2
—
5
31
(3027231) Wheat IgE Ab [Units/volume] in Serum
5
31
1.63
0.43
1.0
1.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
31
1.63
0.43
1.0
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
26
214
1.26
0.43
1.5
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
13
96
1.39
0.43
1.5
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
82
758
1.18
0.42
11.6
9.5
ml/min/173m2
99.0
96.6
0.36
62
562
(3020393) Adenovirus Ag [Presence] in Stool
5
33
1.53
0.41
2.0
2.6
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.1
—
230.7
—
0
15
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
3.8
—
19.1
—
0
16
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
7.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
34
1.49
0.40
2.0
1.3
—
—
—
0
0
(4094501)
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
35
301
1.21
0.40
16.6
12.0
mmol/l
0.8
1.1
0.27
28
218
(3037467) Urinalysis macro (dipstick) panel - Urine
85
791
1.17
0.39
3.6
4.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
46
516
0.84
0.39
1.7
2.0
—
—
—
0
0
(3009343) pH of Capillary blood
35
302
1.21
0.39
16.6
12.1
—
7.4
—
0
9
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
36
1.40
0.38
1.8
1.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
9
70
1.30
0.37
6.4
5.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
9
122
0.72
0.37
1.3
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
13
99
1.34
0.37
1.6
1.5
—
—
—
0
0
(3000492) Spirometry study
5
78
0.63
0.36
1.2
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
30
347
0.83
0.35
2.1
2.0
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
21
173
1.25
0.35
7.0
6.6
%
1.7
1.5
0.43
21
166
(3041096) Erythrocytes [Presence] in Urine by Automated
31
268
1.20
0.34
2.5
3.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
126
1298
0.82
0.34
22.7
17.3
%
38.0
38.8
0.60
112
1166
(3032773) Endomysium IgG Ab [Titer] in Serum
6
46
1.32
0.33
1.0
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
6
46
1.32
0.33
1.0
6.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
45
403
1.17
0.33
3.0
4.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
42
374
1.17
0.33
3.6
3.2
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
12
93
1.32
0.31
3.9
7.8
%
156.0
165.3
0.26
12
93
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
10
130
0.75
0.31
1.7
1.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
78
829
0.88
0.30
3.3
3.2
mmol/l
1.2
1.2
0.41
73
784
(3022217) INR in Platelet poor plasma by Coagulation assay
7
56
1.26
0.30
5.0
13.8
—
1.2
—
0
10
(3005322) IgE [Units/volume] in Serum or Plasma
18
149
1.24
0.29
1.3
1.5
u/ml
238.1
120.2
0.51
18
138
(4010399)
5
71
0.69
0.27
1.2
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
73
0.67
0.26
1.4
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
73
0.67
0.26
1.4
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
73
0.67
0.26
1.4
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
73
0.67
0.26
1.4
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
9
75
1.21
0.25
2.0
1.9
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
25
219
1.17
0.24
1.3
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
36
396
0.88
0.23
1.7
1.8
—
—
—
0
0
(3002256) Pathology report gross observation
14
116
1.23
0.23
1.2
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
21
182
1.18
0.23
3.5
7.0
umol/l
6.1
7.9
0.32
15
149
(3045414) Leukocytes [Presence] in Urine
5
40
1.26
0.22
1.4
1.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
32
288
1.14
0.22
3.0
3.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
41
1.23
0.22
1.8
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
16
187
0.84
0.21
1.6
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
11
0.00
0.21
0.0
2.7
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
30
270
1.14
0.21
3.7
3.6
estimate
0.0
0.0
—
9
96
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
14
0.00
0.20
0.0
6.6
—
—
—
0
0
(3016031) Almond IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.2
—
2.5
—
0
14
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
14
0.00
0.20
0.0
6.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.8
—
—
—
0
0
(3019225) pH of Specimen
6
49
1.23
0.20
2.8
5.9
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
10
122
0.81
0.20
1.2
2.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
52
1.16
0.19
1.0
2.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
65
0.76
0.17
1.8
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
5
69
0.72
0.17
1.8
1.8
—
—
—
0
0
(3008898) HLA-B27 [Presence]
5
69
0.72
0.17
1.0
1.0
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
130
1276
1.14
0.16
16.4
13.5
mg/l
22.2
23.0
0.11
104
939
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
78
1.16
0.15
1.1
2.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
7
86
0.80
0.15
2.6
3.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
8
96
0.82
0.14
1.6
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
18
161
1.13
0.13
1.6
1.4
titre
288.0
677.0
—
5
27
(40768804) Tissue Pathology biopsy report
36
384
0.92
0.13
1.6
1.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
12
137
0.87
0.12
1.0
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
14
124
1.14
0.11
9.0
5.3
e9/l
87.4
66.8
—
9
86
(3011397) Hemoglobin [Presence] in Urine by Test strip
34
319
1.09
0.11
3.7
3.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
31
292
1.08
0.09
1.6
1.8
pmol/l
96.5
96.2
0.01
14
159
(44806118)
5
47
1.07
0.09
2.0
2.3
—
—
—
0
0
(44790048)
5
47
1.07
0.09
2.0
2.3
—
—
—
0
0
(44790047)
5
47
1.07
0.09
2.0
2.3
—
—
—
0
0
(44790049)
5
47
1.07
0.09
2.0
2.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
6
56
1.07
0.09
2.2
2.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
24
256
0.93
0.08
3.0
2.8
ug/g
66.4
68.3
0.04
19
208
(3005033) Fetal Nuchal fold Thickness US
5
62
0.80
0.08
1.4
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
62
0.80
0.08
1.4
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
5
64
0.77
0.08
8.0
3.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
21
225
0.92
0.08
1.5
1.8
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
7
67
1.05
0.08
1.1
1.9
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
6
70
0.85
0.08
1.5
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
7
84
0.83
0.07
1.1
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
9
100
0.89
0.06
1.6
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
16
148
1.09
0.06
2.0
1.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
11
121
0.90
0.06
1.7
2.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
13
140
0.92
0.04
1.8
1.4
%
1.2
1.4
0.50
13
126
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
11
118
0.93
0.03
1.9
1.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
34
349
0.97
0.02
1.9
1.9
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
10
96
1.04
0.00
1.2
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
16
164
0.97
0.00
1.6
1.2
u/ml
7.4
6.6
—
5
59
(3013512) EKG study
15
153
0.98
0.00
4.1
3.1
—
—
—
0
0
(3015736) pH of Urine
44
435
1.02
0.00
3.7
3.3
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
10
102
0.98
0.00
1.3
1.2
u/ml
4.2
4.7
—
5
37
(3044290) Cell count panel - Cerebral spinal fluid
5
52
0.96
0.00
1.0
6.1
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
83.6
—
0
5
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
7
70
1.00
0.00
2.0
2.3
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
7
70
1.00
0.00
1.9
2.1
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
6.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
7.7
—
0
5
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
6
68
0.88
0.00
1.3
1.0
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
8.8
—
0
5
(3017569) Oxygen content in Arterial blood
0
5
0.00
0.00
0.0
15.0
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
5
0.00
0.00
0.0
1.2
—
224.8
—
0
5
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
8
0.00
0.00
0.0
2.9
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
83.2
—
0
5
(3028707) Methadone [Presence] in Urine by Screen method
5
58
0.86
0.00
2.0
1.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
8.2
—
0
5
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
59
1.02
0.00
2.2
1.6
—
—
—
0
0
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
84
0.95
0.00
1.5
1.4
—
—
—
0
0
(3006598) pH of Arterial cord blood
8
87
0.92
0.00
1.0
1.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
7
74
0.94
0.00
1.1
2.0
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
7
0.00
0.00
0.0
10.9
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
6
0.00
0.00
0.0
4.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
0
7
0.00
0.00
0.0
10.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.4
—
3.6
—
0
9
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
9
99
0.90
0.00
1.6
1.3
—
—
—
0
0
(4146454)
0
7
0.00
0.00
0.0
3.6
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.3
—
1.1
—
0
9
(3023511) Choriogonadotropin [Units/volume] in Urine
5
56
0.89
0.00
1.0
1.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
7
76
0.92
0.00
2.4
1.6
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
6
62
0.97
0.00
3.5
4.0
%
29.8
31.0
—
6
42
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
10.8
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
9
99
0.90
0.00
1.6
1.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
59
1.02
0.00
2.2
2.0
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
7
0.00
0.00
0.0
8.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
9
99
0.90
0.00
1.6
1.3
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7
73
0.96
0.00
1.1
1.9
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_OTHER_CHROMOSOME_ABNORMALITI_NOT_ELSEW_CLASSIFIED and mortality.
Females
No dataMales
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_OTHER_CHROMOSOME_ABNORMALITI_NOT_ELSEW_CLASSIFIED | 5.266 [3.59, 7.72] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.006 |
During the follow-up period (1.1.1998 — 31.12.2019), 81 out of 1126 males with Q17_OTHER_CHROMOSOME_ABNORMALITI_NOT_ELSEW_CLASSIFIED died.
Mortality risk
Mortality risk for people of age
years, who have Q17_OTHER_CHROMOSOME_ABNORMALITI_NOT_ELSEW_CLASSIFIED.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | 1.035% |
| 5 | No data | 6.0% |
| 10 | No data | 13.624% |
| 15 | No data | 24.885% |
| 20 | No data | 40.393% |
Relationships between endpoints
↥Index endpoint: Q17_OTHER_CHROMOSOME_ABNORMALITI_NOT_ELSEW_CLASSIFIED – Other chromosome abnormalities, not elsewhere classified
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data